CNQ · CHV.CN
Canada House Cannabis Group Inc.
CA$0.04CA$0.00 (0.0%)
Canada House Cannabis Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
Loading market information…
CNQ · ORIG.CN · CAD
Stock price, earnings
Quote as of Jan 30, 2023, 02:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Origin Therapeutics Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Origin Therapeutics Holdings Inc. functions as an investment firm, predominantly focusing its efforts on the burgeoning psychedelic industry within Canada. Its strategic intent is to finance various stages of development, including scientific research, product conceptualization, manufacturing, quality control, market penetration, and sales of psychedelic substances, alongside any related endeavors. Incorporated in 2020, the company, originally known as 1278700 B.C. Ltd., maintains its main office in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.04CA$0.00 (0.0%)
Canada House Cannabis Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
CA$0.01CA$0.00 (0.0%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01CA$0.00 (0.0%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$0.01-CA$0.01 (-50.0%)
Delta 9 Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.86% below the high.
CA$0.01CA$0.00 (0.0%)
The Hash Corporation: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.03CA$0.00 (0.0%)
Terranueva Corporation: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.03CA$0.00 (0.0%)
Orchid Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.17% below the high.
$0.00$0.00 (0.0%)
TransCanna Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
